The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Interaction of Tau Isoforms with Alzheimer's Disease Abnormally Hyperphosphorylated Tau and in VitroPhosphorylation into the Disease-like Protein
Open accessAbstract
The microtubule-associated protein tau is a family of six isoforms that becomes abnormally hyperphosphorylated and accumulates in neurons undergoing neurodegeneration in the brains of patients with Alzheimer disease (AD). We investigated the isoform-specific interaction of normal tau with AD hyperphosphorylated tau (AD P-tau). We found that the binding of AD P-tau to normal human recombinant tau was tau4L > tau4S > tau4 and tau3L > tau3S > tau3, and that its binding to tau4L was greater than to tau3L. AD P-tau also inhibited the assembly of microtubules promoted by each tau isoform and caused disassembly when added to preassembled microtubules. This inhibition and depolymerization of microtubules by the AD P-tau corresponded directly to the degree of its interaction with the different tau isoforms. In vitro hyperphosphorylation of recombinant tau (P-tau) conferred AD P-tau-like characteristics. Like AD P-tau, P-tau interacted with and sequestered normal tau and inhibited microtubule assembly. These studies suggest that the AD P-tau interacts preferentially with the tau isoforms that have the amino-terminal inserts and four microtubule binding domain repeats and that hyperphosphorylation of tau appears to be sufficient to acquire AD P-tau characteristics. Thus, lack of amino-terminal inserts and extra microtubule binding domain repeat in fetal human brain might be protective from Alzheimer's neurofibrillary degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Self-citationAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939
Phosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Self-citation
Research works printed but not linked: 39
- Alafuzoff, 1987, Acta Neuropathol. (Berl.), 74, 209, 10.1007/BF00688184 · DOI · Paper page
- Drubin, 1986, J. Cell Biol., 103, 2739, 10.1083/jcb.103.6.2739 · DOI · Paper page
- Iqbal, 1986, Lancet, 2, 421, 10.1016/S0140-6736(86)92134-3 · DOI · Paper page
- Grundke-Iqbal, 1986, J. Biol. Chem., 261, 6084, 10.1016/S0021-9258(17)38495-8 · DOI · Paper page
- Himmler, 1989, Mol. Cell. Biol., 9, 1381, 10.1128/MCB.9.4.1381 · DOI · Paper page
- Goedert, 1989, Neuron, 3, 519, 10.1016/0896-6273(89)90210-9 · DOI · Paper page
- Iqbal, 1989, Proc. Natl. Acad. Sci. U. S. A., 86, 5646, 10.1073/pnas.86.14.5646 · DOI · Paper page
- Lee, 1991, Science, 251, 675, 10.1126/science.1899488 · DOI · Paper page
- Goedert, 1992, Neuron, 8, 159, 10.1016/0896-6273(92)90117-V · DOI · Paper page
- Spillantini, 2000, Ann. Neurol., 49, 939, 10.1002/1531-8249(200012)48:6<939::AID-ANA17>3.0.CO;2-1 · doi:10.1002/1531-8249(200012)48:6<939::aid-ana17>3.0.co;2-1
- Alonso, 1996, Nat. Med., 2, 783, 10.1038/nm0796-783 · DOI · Paper page
- Alonso, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 298, 10.1073/pnas.94.1.298 · DOI · Paper page
- Binder, 1985, J. Cell Biol., 101, 1371, 10.1083/jcb.101.4.1371 · DOI · Paper page
- Szendrei, 1993, J. Neurosci. Res., 34, 243, 10.1002/jnr.490340212 · DOI · Paper page
- Seubert, 1995, J. Biol. Chem., 270, 18917, 10.1074/jbc.270.32.18917 · DOI · Paper page
- Hasegawa, 1995, J. Neurochem., 60, 2068, 10.1111/j.1471-4159.1993.tb03491.x · DOI
- Greenberg, 1992, J. Biol. Chem., 267, 564, 10.1016/S0021-9258(18)48531-6 · DOI · Paper page
- Mercken, 1992, Acta Neuropathol., 84, 265, 10.1007/BF00227819 · DOI · Paper page
- Tanaka, 1998, FEBS Lett., 426, 248, 10.1016/S0014-5793(98)00346-9 · DOI
- Grundke-Iqbal, 1988, Brain Res., 464, 43
- Novak, 1991, Proc. Natl. Acad. Sci. U. S. A., 88, 5837, 10.1073/pnas.88.13.5837 · DOI · Paper page
- Singh, 1995, FEBS Lett., 358, 267, 10.1016/0014-5793(94)01445-7 · DOI
- Sanger, 1977, Proc. Natl. Acad. Sci. U. S. A., 74, 5463, 10.1073/pnas.74.12.5463 · DOI · Paper page
- Bensadoun, 1976, Anal. Biochem., 70, 241, 10.1016/S0003-2697(76)80064-4 · DOI · Paper page
- Khatoon, 1992, J. Neurochem., 59, 750, 10.1111/j.1471-4159.1992.tb09432.x · DOI · Paper page
- Alonso, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 6923, 10.1073/pnas.121119298 · DOI · Paper page
- Kremer, 1988, Anal. Biochem., 175, 91, 10.1016/0003-2697(88)90365-X · DOI
- Wisniewski, 1984, J. Neuropathol. Exp. Neurol., 43, 643, 10.1097/00005072-198411000-00008 · DOI
- Wang, 1996, Nat. Med., 2, 871, 10.1038/nm0896-871 · DOI · Paper page
- Arrasate, 1999, FEBS Lett., 446, 199, 10.1016/S0014-5793(99)00210-0 · DOI
- von Bergen, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 5129, 10.1073/pnas.97.10.5129 · DOI · Paper page
- Iqbal, 1995, Neurobiol. Aging, 16, 375, 10.1016/0197-4580(95)00033-B · DOI
- Morishima-Kawashima, 1995, J. Biol. Chem., 270, 823, 10.1074/jbc.270.2.823 · DOI · Paper page
- Goode, 1997, Mol. Biol. Cell, 8, 353, 10.1091/mbc.8.2.353 · DOI · Paper page
- Ruben, 1997, Synapse, 27, 208, 10.1002/(SICI)1098-2396(199711)27:3<208::AID-SYN7>3.0.CO;2-H · DOI
- Liu, 1993, Am. J. Pathol., 142, 387
- Ksiezak-Reding, 1995, J. Neurosci. Res., 41, 583, 10.1002/jnr.490410504 · DOI
- Mori, 1987, Science, 235, 1641, 10.1126/science.3029875 · DOI · Paper page
- Yan, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 7787, 10.1073/pnas.91.16.7787 · DOI · Paper page
Cited by
Tau in Alzheimer Disease and Related Tauopathies
Iqbal, K., Liu, F., Gong, C.-X., & Grundke-Iqbal, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,127
Self-citationTau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
“Thesix human tau isoforms, H 4RL (4R, 2N), H 4S (4R, 1N), H 4 (4R, no N), H 3RL (3R, 2N), H 3RS (3R, 1N), and H 3 (3R, no N), also called fetal tau, are differentially sequestered by AD P-tau, in vitro [79].”
BackgroundTau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Self-citationLiu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04391.x · Cited by 759
Self-citationGong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644
Self-citationMechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Self-citationAgholme, L., Lindström, T., Kågedal, K., Marcusson, J., & Hallbeck, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091363 · Cited by 498
Hanger, D. P., Byers, H. L., Wray, S., Leung, K.-Y., Saxton, M. J., Seereeram, A., Reynolds, C. H., Ward, M. A., & Anderton, B. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703269200 · Cited by 455
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
“Many studies have demonstrated that abnormal hyperphosphorylation of tau is critical to neurodegeneration and promotes its aggregation into tangles (Iqbal et al., 1986; Alonso et al., 1994, 2001a, b, 2004; Lucas et al., 2001; Fath et al., 2002; Jackson et al., 2002; Perez et al., 2002).”
BackgroundSelf-citationPost-translational modifications of tau protein in Alzheimer’s disease
Gong, C.-X., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0221-0 · Cited by 437
Self-citationMicrotubule-associated protein tau in development, degeneration and protection of neurons
Wang, J.-Z., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 398
Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation
Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P. D., & Rogers, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.12.005 · Cited by 390
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
Alonso, A. D. C., Mederlyova, A., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 329
Self-citationTau exon 10 alternative splicing and tauopathies
Liu, F., & Gong, C.-X. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-8 · Cited by 323
Mastroeni, D., McKee, A., Grover, A., Rogers, J., & Coleman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006617 · Cited by 294
Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
Alonso, A. D., Cohen, L. S., Corbo, C., Morozova, V., ElIdrissi, A., Phillips, G., & Kleiman, F. E. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00338 · Cited by 278
Self-citationPolanco, J. C., Scicluna, B. J., Hill, A. F., & Götz, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.709485 · Cited by 272
Alzheimer's disease, a multifactorial disorder seeking multitherapies
Iqbal, K., & Grundke‐Iqbal, I. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.04.006 · Cited by 255
Self-citationPhosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration
Alonso, A. D., Di Clerico, J., Li, B., Corbo, C. P., Alaniz, M. E., Grundke-Iqbal, I., & Iqbal, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110957 · Cited by 236
Self-citationTau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220
“The cytoskeleton proteins show abnormalities during tauopathies, like the inhibition of assembly or deformation of microtubules and invaginations of the nuclear membrane [453,454].”
BackgroundLiu, F., Li, B., Tung, E., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05955.x · Cited by 208
Self-citationPolymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity
Alonso, A. D. C., Li, B., Grundke-Iqbal, I., & Iqbal, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603214103 · Cited by 206
Self-citationMorawski, M., Brückner, G., Jäger, C., Seeger, G., Matthews, R. T., & Arendt, T. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00557.x · Cited by 157
Morawski, M., Brückner, G., Jäger, C., Seeger, G., & Arendt, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.022 · Cited by 156
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, H., Alam, A., San, C.-Y., Eguchi, S., Chen, Q., Lian, Q., & Ma, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.029 · Cited by 122
Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies
Hanes, J., Zilka, N., Bartkova, M., Caletkova, M., Dobrota, D., & Novak, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05869.x · Cited by 109
Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98
Roy, B., & Jackson, G. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu011 · Cited by 75
Molecular mechanism of prion‐like tau‐induced neurodegeneration
Alonso, A. D., Beharry, C., Corbo, C. P., & Cohen, L. S. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.014 · Cited by 53
Self-citationFurther understanding of tau phosphorylation: implications for therapy
Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41
“sufficient to induce tau aggregation, others have shown that tau phosphorylation is enough to induce self-aggregation and that dephosphorylation with alkaline phosphatase, but not deglycosylation [39], or with specific phosphatases [40], prevents or abolishes self-assembly from hyperphosphorylated tau from AD.”
BackgroundBeharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39
Self-citationRetromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Metadata
- Authors
- del C. Alonso, A., Zaidi, T., Novak, M., Barra, H. S., Grundke-Iqbal, I., & Iqbal, K.
- Venue
- Journal of Biological Chemistry
- Published
- 2001-10
- Volume
- 276
- Issue
- 41
- Pages
- 37967-37973
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1593693427
- Cited by
- 160
- References
- 17
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6940 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.